secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scienture Holdings, Inc. (SCNX)
CIK:        0001382574
Form:       8-K
Filed at:   2024-06-20T23:59:59+00:00
Accession:  0001493152-24-024424
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TRxADE Health appoints Subbarao Jayanthi to board, Narasimhan Mani resigns
--------------------------------------------------------------------------

- Subbarao Jayanthi appointed to TRxADE Health board on June 17, 2024.
- Jayanthi is Managing Partner of RxC International, a biopharma strategy consulting firm.
- Narasimhan Mani voluntarily resigned as director on June 17, 2024, with no dispute.
- Jayanthi will receive equity and cash compensation per company independent director policies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382574/000149315224024424/0001493152-24-024424-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382574/000149315224024424/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-024424

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer